The global market for Molecular Diagnostics in Infectious Disease Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.

North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.

This report aims to provide a comprehensive presentation of the global market for Molecular Diagnostics in Infectious Disease Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnostics in Infectious Disease Testing.

The Molecular Diagnostics in Infectious Disease Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Molecular Diagnostics in Infectious Disease Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Molecular Diagnostics in Infectious Disease Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Molecular Diagnostics in Infectious Disease Testing Market Report

Report Metric	Details
Report Name	Molecular Diagnostics in Infectious Disease Testing Market
Segment by Type	Polymerase Chain Reaction (PCR) Isothermal Nucleic Acid Amplification Technology (INAAT) Microarrays Next-Generation Sequencing (NGS) Hybridization Others
Segment by Application	Hospitals Clinics Academic Institutes Laboratories Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, BD, BioMerieux, Thermo Fisher Scientific, Roche, Siemens, Veridex, Luminex, GenMark Diagnostics, Qiagen, Genomix Biotech, BioTheranostics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Molecular Diagnostics in Infectious Disease Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Molecular Diagnostics in Infectious Disease Testing Market report?

Ans: The main players in the Molecular Diagnostics in Infectious Disease Testing Market are Abbott, BD, BioMerieux, Thermo Fisher Scientific, Roche, Siemens, Veridex, Luminex, GenMark Diagnostics, Qiagen, Genomix Biotech, BioTheranostics

What are the Application segmentation covered in the Molecular Diagnostics in Infectious Disease Testing Market report?

Ans: The Applications covered in the Molecular Diagnostics in Infectious Disease Testing Market report are Hospitals, Clinics, Academic Institutes, Laboratories, Others

What are the Type segmentation covered in the Molecular Diagnostics in Infectious Disease Testing Market report?

Ans: The Types covered in the Molecular Diagnostics in Infectious Disease Testing Market report are Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarrays, Next-Generation Sequencing (NGS), Hybridization, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Polymerase Chain Reaction (PCR)

1.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT)

1.2.4 Microarrays

1.2.5 Next-Generation Sequencing (NGS)

1.2.6 Hybridization

1.2.7 Others

1.3 Market by Application

1.3.1 Global Molecular Diagnostics in Infectious Disease Testing Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Academic Institutes

1.3.5 Laboratories

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Perspective (2020-2031)

2.2 Global Molecular Diagnostics in Infectious Disease Testing Growth Trends by Region

2.2.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Region (2020-2025)

2.2.3 Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Region (2026-2031)

2.3 Molecular Diagnostics in Infectious Disease Testing Market Dynamics

2.3.1 Molecular Diagnostics in Infectious Disease Testing Industry Trends

2.3.2 Molecular Diagnostics in Infectious Disease Testing Market Drivers

2.3.3 Molecular Diagnostics in Infectious Disease Testing Market Challenges

2.3.4 Molecular Diagnostics in Infectious Disease Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue

3.1.1 Global Top Molecular Diagnostics in Infectious Disease Testing Players by Revenue (2020-2025)

3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Players (2020-2025)

3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Molecular Diagnostics in Infectious Disease Testing Revenue

3.4 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio

3.4.1 Global Molecular Diagnostics in Infectious Disease Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics in Infectious Disease Testing Revenue in 2024

3.5 Global Key Players of Molecular Diagnostics in Infectious Disease Testing Head office and Area Served

3.6 Global Key Players of Molecular Diagnostics in Infectious Disease Testing, Product and Application

3.7 Global Key Players of Molecular Diagnostics in Infectious Disease Testing, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Type

4.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Type (2020-2025)

4.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2026-2031)

5 Molecular Diagnostics in Infectious Disease Testing Breakdown Data by Application

5.1 Global Molecular Diagnostics in Infectious Disease Testing Historic Market Size by Application (2020-2025)

5.2 Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Molecular Diagnostics in Infectious Disease Testing Market Size (2020-2031)

6.2 North America Molecular Diagnostics in Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2020-2025)

6.4 North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Molecular Diagnostics in Infectious Disease Testing Market Size (2020-2031)

7.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2020-2025)

7.4 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size (2020-2031)

8.2 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2020-2025)

8.4 Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size (2020-2031)

9.2 Latin America Molecular Diagnostics in Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2020-2025)

9.4 Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size (2020-2031)

10.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2020-2025)

10.4 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Introduction

11.1.4 Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 BD

11.2.1 BD Company Details

11.2.2 BD Business Overview

11.2.3 BD Molecular Diagnostics in Infectious Disease Testing Introduction

11.2.4 BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.2.5 BD Recent Development

11.3 BioMerieux

11.3.1 BioMerieux Company Details

11.3.2 BioMerieux Business Overview

11.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Introduction

11.3.4 BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.3.5 BioMerieux Recent Development

11.4 Thermo Fisher Scientific

11.4.1 Thermo Fisher Scientific Company Details

11.4.2 Thermo Fisher Scientific Business Overview

11.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Introduction

11.4.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.4.5 Thermo Fisher Scientific Recent Development

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Introduction

11.5.4 Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.5.5 Roche Recent Development

11.6 Siemens

11.6.1 Siemens Company Details

11.6.2 Siemens Business Overview

11.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Introduction

11.6.4 Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.6.5 Siemens Recent Development

11.7 Veridex

11.7.1 Veridex Company Details

11.7.2 Veridex Business Overview

11.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Introduction

11.7.4 Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.7.5 Veridex Recent Development

11.8 Luminex

11.8.1 Luminex Company Details

11.8.2 Luminex Business Overview

11.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Introduction

11.8.4 Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.8.5 Luminex Recent Development

11.9 GenMark Diagnostics

11.9.1 GenMark Diagnostics Company Details

11.9.2 GenMark Diagnostics Business Overview

11.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Introduction

11.9.4 GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.9.5 GenMark Diagnostics Recent Development

11.10 Qiagen

11.10.1 Qiagen Company Details

11.10.2 Qiagen Business Overview

11.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Introduction

11.10.4 Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.10.5 Qiagen Recent Development

11.11 Genomix Biotech

11.11.1 Genomix Biotech Company Details

11.11.2 Genomix Biotech Business Overview

11.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Introduction

11.11.4 Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.11.5 Genomix Biotech Recent Development

11.12 BioTheranostics

11.12.1 BioTheranostics Company Details

11.12.2 BioTheranostics Business Overview

11.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Introduction

11.12.4 BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

11.12.5 BioTheranostics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott

Biomerieux

Thermo Fisher Scientific

List of Tables

Table 1. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Polymerase Chain Reaction (PCR)

Table 3. Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT)

Table 4. Key Players of Microarrays

Table 5. Key Players of Next-Generation Sequencing (NGS)

Table 6. Key Players of Hybridization

Table 7. Key Players of Others

Table 8. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2020-2025)

Table 12. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2026-2031)

Table 14. Molecular Diagnostics in Infectious Disease Testing Market Trends

Table 15. Molecular Diagnostics in Infectious Disease Testing Market Drivers

Table 16. Molecular Diagnostics in Infectious Disease Testing Market Challenges

Table 17. Molecular Diagnostics in Infectious Disease Testing Market Restraints

Table 18. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players (2020-2025)

Table 20. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2024)

Table 21. Ranking of Global Top Molecular Diagnostics in Infectious Disease Testing Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Molecular Diagnostics in Infectious Disease Testing, Headquarters and Area Served

Table 24. Global Key Players of Molecular Diagnostics in Infectious Disease Testing, Product and Application

Table 25. Global Key Players of Molecular Diagnostics in Infectious Disease Testing, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2020-2025)

Table 29. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Type (2026-2031)

Table 31. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2020-2025)

Table 33. Global Molecular Diagnostics in Infectious Disease Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Application (2026-2031)

Table 35. North America Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2026-2031) & (US$ Million)

Table 50. Abbott Company Details

Table 51. Abbott Business Overview

Table 52. Abbott Molecular Diagnostics in Infectious Disease Testing Product

Table 53. Abbott Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 54. Abbott Recent Development

Table 55. BD Company Details

Table 56. BD Business Overview

Table 57. BD Molecular Diagnostics in Infectious Disease Testing Product

Table 58. BD Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 59. BD Recent Development

Table 60. BioMerieux Company Details

Table 61. BioMerieux Business Overview

Table 62. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product

Table 63. BioMerieux Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 64. BioMerieux Recent Development

Table 65. Thermo Fisher Scientific Company Details

Table 66. Thermo Fisher Scientific Business Overview

Table 67. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product

Table 68. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 69. Thermo Fisher Scientific Recent Development

Table 70. Roche Company Details

Table 71. Roche Business Overview

Table 72. Roche Molecular Diagnostics in Infectious Disease Testing Product

Table 73. Roche Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 74. Roche Recent Development

Table 75. Siemens Company Details

Table 76. Siemens Business Overview

Table 77. Siemens Molecular Diagnostics in Infectious Disease Testing Product

Table 78. Siemens Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 79. Siemens Recent Development

Table 80. Veridex Company Details

Table 81. Veridex Business Overview

Table 82. Veridex Molecular Diagnostics in Infectious Disease Testing Product

Table 83. Veridex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 84. Veridex Recent Development

Table 85. Luminex Company Details

Table 86. Luminex Business Overview

Table 87. Luminex Molecular Diagnostics in Infectious Disease Testing Product

Table 88. Luminex Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 89. Luminex Recent Development

Table 90. GenMark Diagnostics Company Details

Table 91. GenMark Diagnostics Business Overview

Table 92. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product

Table 93. GenMark Diagnostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 94. GenMark Diagnostics Recent Development

Table 95. Qiagen Company Details

Table 96. Qiagen Business Overview

Table 97. Qiagen Molecular Diagnostics in Infectious Disease Testing Product

Table 98. Qiagen Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 99. Qiagen Recent Development

Table 100. Genomix Biotech Company Details

Table 101. Genomix Biotech Business Overview

Table 102. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product

Table 103. Genomix Biotech Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 104. Genomix Biotech Recent Development

Table 105. BioTheranostics Company Details

Table 106. BioTheranostics Business Overview

Table 107. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product

Table 108. BioTheranostics Revenue in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025) & (US$ Million)

Table 109. BioTheranostics Recent Development

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

Table 113. Authors List of This Report

List of Figures

Figure 1. Molecular Diagnostics in Infectious Disease Testing Picture

Figure 2. Global Molecular Diagnostics in Infectious Disease Testing Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Type: 2024 VS 2031

Figure 4. Polymerase Chain Reaction (PCR) Features

Figure 5. Isothermal Nucleic Acid Amplification Technology (INAAT) Features

Figure 6. Microarrays Features

Figure 7. Next-Generation Sequencing (NGS) Features

Figure 8. Hybridization Features

Figure 9. Others Features

Figure 10. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Application: 2024 VS 2031

Figure 12. Hospitals Case Studies

Figure 13. Clinics Case Studies

Figure 14. Academic Institutes Case Studies

Figure 15. Laboratories Case Studies

Figure 16. Others Case Studies

Figure 17. Molecular Diagnostics in Infectious Disease Testing Report Years Considered

Figure 18. Global Molecular Diagnostics in Infectious Disease Testing Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Molecular Diagnostics in Infectious Disease Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Region: 2024 VS 2031

Figure 21. Global Molecular Diagnostics in Infectious Disease Testing Market Share by Players in 2024

Figure 22. Global Top Molecular Diagnostics in Infectious Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Infectious Disease Testing as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Infectious Disease Testing Revenue in 2024

Figure 24. North America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2020-2031)

Figure 26. United States Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2020-2031)

Figure 30. Germany Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Molecular Diagnostics in Infectious Disease Testing Market Share by Region (2020-2031)

Figure 38. China Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2020-2031)

Figure 46. Mexico Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Share by Country (2020-2031)

Figure 50. Turkey Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Molecular Diagnostics in Infectious Disease Testing Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Abbott Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 54. BD Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 55. BioMerieux Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 56. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 57. Roche Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 58. Siemens Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 59. Veridex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 60. Luminex Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 61. GenMark Diagnostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 62. Qiagen Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 63. Genomix Biotech Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 64. BioTheranostics Revenue Growth Rate in Molecular Diagnostics in Infectious Disease Testing Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Molecular Infectious Disease Testing Market Research Report 2025

Global Viral Molecular Diagnostics Market Research Report 2024

Global Infectious Diseases Molecular Diagnostics Market Research Report 2025

Veterinary Molecular Diagnostics Market

Global Molecular Microbiology Market Insights Forecast to 2030

Global Point of care Molecular Diagnostic Solution Market Research Report 2025

Global Infectious Diseases Molecular Diagnostics Kit Market Research Report 2025

In Vitro Assays to Diagnose Infectious Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Molecular Diagnostics and NAT Market Research Report 2024

Global Infectious Disease Testing And Diagnostic Market Research Report 2024

Global Nucleic Acids for Molecular Diagnosis Market Research Report 2024

Global Sexually Transmitted Diseases Diagnostics Market Research Report 2024

Global Infectious Diseases Diagnostic Market Insights Forecast to 2030

Molecular Diagnostics Devices and Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Molecular Diagnostic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Molecular Diagnostics Cancer Market Insights Forecast to 2030

Global Infectious Disease Diagnosis Market Insights Forecast to 2030

Global In Vitro Testing for Infectious Diseases Market Research Report 2024

Global Sexually Transmitted Infection Diagnostics Kit Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions